AI assistant
Sending…
AbbVie Inc. — Director's Dealing 2018
Feb 21, 2018
29755_dirs_2018-02-20_80b48569-a48e-49f8-bc29-cf33c3387ab4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2018-02-19
Reporting Person: Michael Robert A. (VP, Controller)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-02-19 | Common stock, $0.01 par value | F | 838 | $118.60 | Disposed | 14549 | Direct |
| 2018-02-20 | Common stock, $0.01 par value | S | 400 | $120.2901 | Disposed | 14149 | Direct |
| 2018-02-20 | Common stock, $0.01 par value | S | 592 | $120.33 | Disposed | 13557 | Direct |
More from AbbVie Inc.
Regulatory Filings
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 12
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 29
Capital/Financing Update
2026
Apr 3
Major Shareholding Notification
2026
Mar 26
Proxy Solicitation & Information Statement
2026
Mar 23
Proxy Solicitation & Information Statement
2026
Mar 23
Capital/Financing Update
2026
Mar 4
Director's Dealing
2026
Mar 4